Bruker (BRKR): are the analysts right?

Bruker · Health Care · ref. ETF XLV · 50 calls · price $59.5
What the company does: Bruker fabrique des instruments scientifiques et solutions analytiques.
📈 1-year price
$58.25+37.5% over range
Jul 8, 25low $29.35 · high $62.7Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
43% recommend buying · 7 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on BRKR

High target · 1 analyst$65+9.2%
Median target · 7 analysts$45-24.4%
Low target · 1 analyst$35-41.2%
Current price$59.5

🗳️ The analyst consensus

Analyst breakdown · 7 (6 months)
Strong Buy0%
Buy43%
Hold43%
Sell14%
Strong Sell0%

💰 Bruker dividend

0.33%annual yield
That's ~$0.20 per share per year.

✅ Historical analyst reliability on BRKR

Most reliable analysts on BRKR (% profitable · 365j · ≥2 calls)
Barclays 50% -6.6% 4
Guggenheim 0% -16.2% 3

📊 What $1,000 invested in Bruker would be worth

In short — $1,000 invested in Bruker 10 years ago would be worth $2,480 today, i.e. +10%/yr on average. Best year: 2019 (+71%), worst: 2024 (-20%). Price performance, excluding dividends.

If I'd invested $1,000 in Bruker

InvestmentWorth todayGain
1 years ago$1,027+3%
3 years ago$880-12%
5 years ago$1,112+11%
10 years ago$2,480+148%
since inception (2000)$1,356+36%

Return by year (Bruker)

YearReturn$1,000 invested at year start
2026 (YTD)+28%$1,277 (+28%)
2025-20%$1,027 (+3%)
2024-20%$819 (-18%)
2023+8%$880 (-12%)
2022-19%$717 (-28%)
2021+55%$1,112 (+11%)
2020+6%$1,181 (+18%)
2019+71%$2,021 (+102%)
2018-13%$1,753 (+75%)
2017+62%$2,841 (+184%)
2016-13%$2,480 (+148%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on BRKR

Barclays
Jun 24, 26
▲ Overweight · 🎯$60
Price at call : $60.89 — upside -1%
Today : $59.5 — upside +1%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jun 24, 27
JP Morgan
Jun 8, 26
▲ Overweight · 🎯$65
Price at call : $57.24 — upside +14%
Today : $59.5 — upside +9%
🎯 on BRKR : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Jun 8, 27
UBS
May 8, 26
■ Neutral neutral · not a buy · 🎯$45
Price at call : $44.16 — gap to target +2%
Today : $59.5 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : May 8, 27
Citigroup
May 7, 26
■ Neutral neutral · not a buy · 🎯$44
Price at call : $44.16 — gap to target -0%
Today : $59.5 — gap to target -26%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 7, 27
TD Cowen
May 7, 26
■ Hold neutral · not a buy · 🎯$45
Price at call : $44.16 — gap to target +2%
Today : $59.5 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : May 7, 27
Barclays
May 7, 26
▲ Overweight · 🎯$53
Price at call : $44.16 — upside +20%
Today : $59.5 — upside -11%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : May 7, 27
Barclays
Apr 15, 26
▲ Overweight · 🎯$45
Price at call : $38.94 — upside +16%
Today : $59.5 — upside -24%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 15, 27
Barclays
Apr 14, 26
▲ Overweight · 🎯$45
Price at call : $39.48 — upside +14%
Today : $59.5 — upside -24%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 14, 27
Guggenheim
Mar 30, 26
▲ Buy · 🎯$50
Price at call : $36.12 — upside +38%
Today : $59.5 — upside -16%
🎯 on BRKR : 0% (3 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Mar 30, 27
Citigroup
Feb 13, 26
■ Neutral neutral · not a buy · 🎯$40
Price at call : $38.12 — gap to target +5%
Today : $59.5 — gap to target -33%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Feb 13, 27
Goldman Sachs
Feb 13, 26
▼ Sell · 🎯$35
Price at call : $38.12 — upside -8%
Today : $59.5 — upside -41%
🎯 on BRKR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Feb 13, 27
TD Cowen
Feb 13, 26
■ Hold neutral · not a buy · 🎯$43
Price at call : $38.12 — gap to target +13%
Today : $59.5 — gap to target -28%
🎯 on BRKR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Feb 13, 27
Barclays
Feb 13, 26
▲ Overweight · 🎯$50
Price at call : $38.12 — upside +31%
Today : $59.5 — upside -16%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 13, 27
Guggenheim
Jan 26, 26
▲ Buy · 🎯$58
Price at call : $47.67 — upside +22%
Today : $59.5 — upside -3%
🎯 on BRKR : 0% (3 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jan 26, 27
Citigroup
Jan 16, 26
■ Neutral neutral · not a buy · 🎯$53
Price at call : $49.84 — gap to target +6%
Today : $59.5 — gap to target -11%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Jan 16, 27
TD Cowen
Jan 7, 26
■ Hold neutral · not a buy · 🎯$53
Price at call : $52.48 — gap to target +1%
Today : $59.5 — gap to target -11%
🎯 on BRKR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Jan 7, 27
Guggenheim
Jan 5, 26
▲ Buy · 🎯$53
Price at call : $52.67 — upside +1%
Today : $59.5 — upside -11%
🎯 on BRKR : 0% (3 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jan 5, 27
Barclays
Dec 15, 25
▲ Overweight · 🎯$55
Price at call : $44.96 — upside +22%
Today : $59.5 — upside -8%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 15, 26
JP Morgan
Dec 15, 25
▲ Overweight · 🎯$55
Price at call : $44.96 — upside +22%
Today : $59.5 — upside -8%
🎯 on BRKR : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Dec 15, 26
Wells Fargo
Dec 15, 25
▲ Overweight · 🎯$55
Price at call : $44.96 — upside +22%
Today : $59.5 — upside -8%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Dec 15, 26
▲ Buy · 🎯$60
Price at call : $45.67 — upside +31%
Today : $59.5 — upside +1%
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Dec 15, 26
▲ Outperform · 🎯$60
Price at call : $46.37 — upside +29%
Today : $59.5 — upside +1%
🎯 on BRKR : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Dec 10, 26
▼ Sell · 🎯$40
Price at call : $45.36 — upside -12%
Today : $59.5 — upside -33%
🎯 on BRKR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Dec 9, 26
Rothschild & Co
Nov 20, 25
▲ Buy · 🎯$60
Price at call : $43.84 — upside +37%
Today : $59.5 — upside +1%
🎯 on BRKR : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 20, 26
Wells Fargo
Nov 5, 25
▲ Overweight · 🎯$48
Price at call : $39.31 — upside +22%
Today : $59.5 — upside -19%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Nov 5, 26
TD Cowen
Nov 4, 25
■ Hold neutral · not a buy · 🎯$42
Price at call : $40.2 — gap to target +4%
Today : $59.5 — gap to target -29%
🎯 on BRKR : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Nov 4, 26
UBS
Nov 4, 25
■ Neutral neutral · not a buy · 🎯$43
Price at call : $40.2 — gap to target +7%
Today : $59.5 — gap to target -28%
🎯 on BRKR : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Nov 4, 26
Barclays
Nov 4, 25
▲ Overweight · 🎯$45
Price at call : $40.38 — upside +11%
Today : $59.5 — upside -24%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Nov 4, 26
Barclays
Oct 2, 25
▲ Overweight · 🎯$40
Price at call : $36.98 — upside +8%
Today : $59.5 — upside -33%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 2, 26
Wells Fargo
Aug 5, 25
▲ Overweight · 🎯$50
Price at call : $30.66 — upside +63%
Today : $59.5 — upside -16%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Aug 5, 26
Stifel
Aug 5, 25
■ Hold neutral · not a buy · 🎯$40
Price at call : $32.07 — gap to target +25%
Today : $59.5 — gap to target -33%
🎯 on BRKR : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Aug 5, 26
Citigroup
Aug 4, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $32.07 — gap to target +18%
Today : $59.5 — gap to target -36%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Aug 4, 26
Barclays
Aug 4, 25
▲ Overweight · 🎯$43
Price at call : $32.07 — upside +34%
Today : $59.5 — upside -28%
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Aug 4, 26
Jefferies
Aug 4, 25
▲ Buy · 🎯$60
Price at call : $32.07 — upside +87%
Today : $59.5 — upside +1%
🎯 on BRKR : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Aug 4, 26
▲ Buy · 🎯$50
Price at call : $41.8 — upside +20%
Today : $59.5 — upside -16%
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Jun 26, 26
Citigroup
May 22, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $36.34 — gap to target +10%
Today : $59.5 — gap to target -33%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 22, 26
UBS
May 8, 25
■ Neutral neutral · not a buy · 🎯$45
Price at call : $37.52 — gap to target +20%
Today : $59.5 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : May 8, 26
Barclays
May 8, 25
▲ Overweight · 🎯$46
Price at call : $37.52 — upside +23%
Today : $59.5 — upside -23%
Expected +23% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+15.3%
stock +15% · XLV +8%
■ Neutral neutral · not a buy · 🎯$45
Price at call : $37.52 — gap to target +20%
Today : $59.5 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : May 8, 26
Stifel
May 8, 25
■ Hold neutral · not a buy · 🎯$48
Price at call : $37.52 — gap to target +28%
Today : $59.5 — gap to target -19%
🎯 on BRKR : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : May 8, 26
Wells Fargo
Apr 17, 25
▲ Overweight · 🎯$60
Price at call : $35.98 — upside +67%
Today : $59.5 — upside +1%
Expected +67% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
+14.2%
stock +14% · XLV +11%
Barclays
Apr 10, 25
▲ Overweight · 🎯$50
Price at call : $38.76 — upside +29%
Today : $59.5 — upside -16%
Expected +29% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+0.8%
stock +1% · XLV +8%
Citigroup
Apr 7, 25
▲ Buy · 🎯$50
Price at call : $36.36 — upside +38%
Today : $59.5 — upside -16%
Expected +38% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56.8% · +16.5% (118 calls)
+5.2%
stock +5% · XLV +13%
Guggenheim
Feb 24, 25
▲ Buy
Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 0% (3 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
-21.8%
stock -22% · XLV +6%
Stifel
Feb 14, 25
■ Hold neutral · not a buy · 🎯$57
Price at call : $50.75 — gap to target +12%
Today : $59.5 — gap to target -4%
🎯 on BRKR : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Feb 14, 26
Barclays
Feb 14, 25
▲ Overweight · 🎯$60
Price at call : $50.04 — upside +20%
Today : $59.5 — upside +1%
Expected +20% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-23.8%
stock -24% · XLV +9%
Barclays
Feb 10, 25
▲ Overweight · 🎯$65
Price at call : $51.13 — upside +27%
Today : $59.5 — upside +9%
Expected +27% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 50% (4 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-18.7%
stock -19% · XLV +6%
Guggenheim
Jan 17, 25
▲ Buy
Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 0% (3 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
-12.4%
stock -12% · XLV +11%
Guggenheim
Dec 19, 24
▲ Buy · 🎯$72
Price at call : $57 — upside +26%
Today : $59.5 — upside +21%
Expected +26% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 0% (3 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
-14.4%
stock -14% · XLV +13%
▲ Buy · 🎯$80
Price at call : $57.18 — upside +40%
Today : $59.5 — upside +34%
Expected +40% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
-20.1%
stock -20% · XLV +12%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)